Latest news with #NiftyIndex
Economic Times
28-05-2025
- Business
- Economic Times
Deploy Bull Call Spread in Nifty to benefit from bullish view, volatility
The Nifty Index opened on a negative note on Tuesday and witnessed highly volatile swings. The session turned into a roller-coaster ride with sharp and fast moves on both sides during the first the latter half, the index gradually drifted lower in a slow and steady manner, eventually closing with losses of around 170 points, near the 24,820 mark.'On the daily chart, Nifty formed a bearish candle with wicks on both ends, indicating
&w=3840&q=100)
Business Standard
28-05-2025
- Business
- Business Standard
Stocks to buy today: Bullish trend seen in Titagarh Rail, Cholamandalam Fin
Nifty trading strategy, Nifty Options data The Nifty Index opened on a negative note and witnessed highly volatile swings on Tuesday. The session turned into a roller-coaster ride with sharp and fast moves on both sides during the first half. In the latter half, the index gradually drifted lower in a slow and steady manner, eventually closing with losses of around 170 points, near the 24,820-mark. On the daily chart, Nifty share price has formed a bearish candle with wicks on both ends, indicating selling pressure at higher levels, while buying interest near the lower zones. Now it has to cross and hold above 24,900 zones for an up move towards 25,100, followed by 25,200. Else, weakness could be seen towards 24,700 and 24,600 zones. Further, as per the Nifty Options data, Maximum Call OI is at 25,000 and then at 25,500 strike, while Maximum Put OI is at 24,500 and then at 25,000 strike. Call writing is seen at 24,800, followed by 24,900 strike, while Put writing is seen at 24,400 and then 24,800 strike. Option data suggests a broader trading range in between 24,300 to 25,300 zones while an immediate range lies between 24,600 to 25,000 levels. Bank Nifty Outlook The Bank Nifty Index formed a high wave candle on the daily scale on Tuesday as the buying is visible at lower level support base, but the momentum is missing at higher zones. Now, it has to hold above 55,250 zone for an up move towards 55,750, then 56,000 levels. On the downside, support is seen at 55,250, then 55,000 zones. Stocks to Buy Today for Upside, May 28: Buy Cholamandalam Investment and Finance stock | CMP: ₹1,665 | Stop Loss: ₹1,610 | Share price target: ₹1,775 Cholamandalam Investment stock has formed a bullish 'cup and handle pattern' near the all-time high zones, suggesting an upward trend. It is respecting its 50-DEMA with slight dips being bought into. The RSI indicator is rising which confirms the positive momentum in Cholamandalam Investment share price. Tata Chemicals share price has broken out of a consolidation zone on the daily scale with higher than average traded volumes. The MACD is positively placed which has bullish implications. Titagarh Rail Systems share price has formed a 'pennant' pattern on the daily scale, which suggests a continuation of the uptrend. The ADX line is rising, which confirms the strength of the uptrend. Disclaimer: This article is by Chandan Taparia, head derivatives & technicals, wealth management at Motilal Oswal Financial Services. Views expressed are his own.
Economic Times
14-05-2025
- Business
- Economic Times
‘Sovereign stupidity' and currency debasement make gold a smart hedge in volatile times: Sahil Kapoor
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel In an exclusive conversation, Sahil Kapoor , Market Strategist and Head of Products at DSP Mutual Fund, shares his sharp take on the ongoing market volatility driven by geopolitical tensions, trade wars, and muted corporate highlights gold's continued strength as both a hedge and a wealth-building asset amid what he terms 'sovereign stupidity' and global currency debasement With valuations stretched across segments and earnings growth under pressure, he advises a cautious and value-focused investment approach while positioning gold and even silver as smart plays in the current macroeconomic landscape. Edited Excerpts –A) The outcome of either event is unknown. What is more certain is that these events are either growth detractors or non-events. In the case of the ongoing trade wars, history shows that there are no winners when trade barriers are the long term, we may see some benefits from tariffs in making certain economies more robust, but their consequences for a world built on global trade are unhealthy. We are not experts on wars or their one thing is clear: for corporate earnings, events such as war can either pose downside risks or be non-events. Investors are better served by remaining cautious, given the valuation backdrop.A) A diversified mix of assets-including domestic and global equities, precious metals, and bonds-is a robust allocation exact proportions should be tailored to individual goals and guided by valuation frameworks for each asset class.A) As of 28th April 2025, 18 Nifty firms have reported their numbers. Sales growth stands at 5%, while profit growth is 4.8%. Nifty firms have now cumulatively reported single-digit profit growth in most of the last four contrast, the Nifty Index's trailing twelve-month price-to-earnings (P/E) ratio is close to 22 times. The return on equity (ROE) for the index is at 15.5%.This valuation mix leaves little on the table in terms of a margin of safety. Corporate earnings remain muted and a cause for concern.A) Gold has been a hedge against global currency debasement and what I have dubbed as 'Sovereign Stupidity'. As per my theoretical model to value Gold, the midpoint of valuations comes close to $ it is very hard to value assets like precious metals and hence it makes sense to remain long in the ongoing Gold bull market and not second guess where it ends. From a risk reward stand point, Silver may offer better odds for investors at this time.A) As of 28th April 2025, Nifty MIDSMALL 400 Index, the SMID focussed index was trading at 33.2 times. Earnings growth for this cohort is in single digits, and it also trades at a 90% premium to world midcap numbers when put in the right context tell you that the margin of safety is missing. Unless valuations become attractive investors should only use a SIP route in this segment and avoid lumpsums and performance chasing.A) Stocks in the BFSI segment, particularly private banks, a few NBFCs, select auto and consumption companies along with the healthcare sectors offers value on a bottoms up basis.Q) How are FIIs viewing Indian markets? We have seen some net buying in the past few sessions, but for the month, FIIs have pulled out more than Rs 13,000 crore from the cash segment of Indian equity markets.A) All investors—whether institutional or retail, domestic or foreign—are broadly return chasers. Our tendency to label investor flows as FII, DII, or SIP can be key impact of FII flows is not on stock market returns per se, but on India's balance of payments. That segment is currently doing fine, but the global trade war has made it more volatile.A) We were valuations focussed and continue to remain so. We may also want to take benefit of cheaper prices if these events and triggers create value in pockets of high quality.(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)
Time of India
13-05-2025
- Business
- Time of India
Pharma Cos Slip on US Move to Cut Prices
HighlightsSeveral pharmaceutical shares, including Sun Pharmaceuticals and Ajanta Pharma, underperformed on a day when the broader market saw a nearly 4 percent rally, following President Donald Trump's announcement of plans to cut US prescription drug prices by 30 to 80 percent. The Nifty Pharma Index, despite a 0.2 percent increase on the day, is down 10 percent year-to-date, contrasting with a 5 percent gain in the benchmark Nifty Index. Analysts suggest that while the proposed executive order primarily affects the branded drugs segment, which comprises 90 percent of the US market, Indian pharmaceutical companies mainly operate in the generics market, thus facing limited risks from these changes. Several pharmaceutical shares underperformed on Monday despite a strong broad market rally, after US President Donald Trump announced plans to sign an executive order slashing prescription drug prices in the US to match those in favoured nations, implying cuts of 30 per cent to 80 per cent. Sun Pharmaceuticals fell 3.2 per cent, Ajanta Pharma slipped 2.3 per cent, and Glenmark and Divi's Labs lost over 1 per cent each. Biocon dipped 0.5 per cent. The Nifty Pharma Index ended 0.2 per cent higher Monday after tumbling almost 2.4 per cent earlier in the day in response to Trump's remarks. The Sensex and Nifty jumped nearly 4 per cent—posting their biggest single-day gains in four years. Of the 20 stocks in Nifty Pharma, 13 gained and seven declined. 'The order implies a 30-80 per cent expected cut to align US drug prices with other regulated markets. But such cuts are commercially unviable for pharma firms, especially those with low-double-digit margins,' said Nikhil Ranka, CIO at Nuvama Alternates. 'That's why companies like Sun Pharma, which derives around 40 per cent revenues from the US, saw declines.' Ranka said most pharma stocks rebounded after an initial knee-jerk reaction, as the proposed changes are not expected to be immediately enforceable or impactful. 'Pharma stocks could resume their uptrend in the coming sessions,' he said. Year-to-date, the Nifty Pharma Index is down 10 per cent, compared with a 5 per cent gain in the benchmark Nifty. Bhavesh Gandhi, lead analyst for pharma and healthcare at YES Securities, said the proposed policy primarily targets the branded drugs segment, which accounts for 90 per cent of the US market. Indian companies cater mostly to the remaining 10 per cent — the generics space — where prices are already low. 'Sun Pharma, with some exposure to the branded segment, may face limited risk. But for now, the reaction is largely sentimental, and the real impact will depend on how earnings shape up,' Gandhi said.
&w=3840&q=100)
Business Standard
07-05-2025
- Business
- Business Standard
Bharti Airtel, Polycab: Chandan Taparia of MOFSL picks these stocks to buy
Nifty Index opened positive but failed to hold its opening levels above 24,500 zones and sank sharply by 130 points in the first hour. It was followed by the index moving in a very narrow band of around 50-60 points for the rest of the day. It formed a bearish candle on daily frame to close with losses of around 80 points and has started to form lower highs from the last two sessions. Now it has to cross and hold above 24,400 zones for strength to regain towards 24,650 then 24,750 zones while supports can be seen at 24,200 then 24,050 zones. On option front, Maximum Call OI is at 24,500 then 25,000 strike while Maximum Put OI is at 24,400 then 24,000 strike. Call writing is seen at 24,400 then 24,500 strike while Put writing is seen at 24,400 then 24,200 strike. Option data suggests a broader trading range in between 23,800 to 24,800 zones while an immediate range between 24,100 to 24,600 levels. Bank Nifty Index opened on a flattish note but failed to hold 55,000 zones and gradually drifted lower towards 54,200 zones in the latter part of the session. It formed a Bearish candle on daily scale as selling pressure is seen at higher zones to close with losses of around 650 points below 54,300 zones. Index has seen a decent profit booking of more than 2000 points in last few sessions as some pause is seen at higher zones. Now till it holds below 54500 zones weakness could be seen towards 54,000 then 53,750 levels while on the upside hurdle is seen at 54,500 then 54,750 levels. Stock recommendations Buy BHARTIARTL | CMP ₹1902 | SL ₹1860 | TGT ₹1980 Bharti Airtel Stock has retested its breakout from a consolidation zone and headed up with higher than average traded volumes. The ADX line is rising which confirms the strength of the uptrend. Buy POLYCAB | CMP ₹5909 | SL ₹5725 | TGT ₹6310 Polycab share price has broken out from an ascending triangle pattern on the daily chart and closed above its 100 DEMA. The MACD line is rising which confirms the bullish momentum. Here are the Top STOCKS TO WATCH Today Oberoi Realty stock has breached below its key support levels on the daily chart with a large bodied bearish candle. The Stochastic indicator is declining which confirms the bearish sentiment. (Disclaimer: This article is by Chandan Taparia, head derivatives & technicals, wealth management at Motilal Oswal Financial Services. Views expressed are his own.)
